Resistance to antidepressant medications and short-term clinical response to ECT

American Journal of Psychiatry

Volumn 153, Issue 8, 1996, Pages 985-992

  Prudic, Joan ^a   Haskett, Roger F ^b   Mulsant, Benoit ^b   Malone, Kevin M ^b   Pettinati, Helen M ^b   Stephens, Stephani ^b   Greenberg, Robert ^b   Rifas, Sheryl L ^b   Sackeim, Harold A ^b  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; AMOXAPINE; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; CENTRAL STIMULANT AGENT; HETEROCYCLIC COMPOUND; LITHIUM; MONOAMINE OXIDASE INHIBITOR; PSYCHOTROPIC AGENT; SEROTONIN UPTAKE INHIBITOR; TRAZODONE; VENLAFAXINE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG RESISTANCE; ELECTROCONVULSIVE THERAPY; FEMALE; HAMILTON SCALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; PRIORITY JOURNAL; QUESTIONNAIRE; TREATMENT OUTCOME;

EID: 0029836080     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/ajp.153.8.985     Document Type: Article

References (40)

1. Kalinowsky LB, Hoch PH: Shock Treatments, Psychosurgery and Other Somatic Treatments in Psychiatry. New York, Grune & Stratton, 1952
2. Fink M: Convulsive Therapy: Theory and Practice. New York, Raven Press, 1979
3. The Practice of Electroconvulsive Therapy: Recommendations for Treatment, Training, and Privileging: A Task Force Report of the American Psychiatric Association. Washington, DC, APA, 1990
4. Weiner RD, Coffey CE: Indications for use of electroconvulsive therapy, in American Psychiatric Press Review of Psychiatry, vol 7. Edited by Frances AJ, Hales RE. Washington, DC, American Psychiatric Press, 1988, pp 458-481
5. Sackeim HA: Central issues regarding the mechanisms of action of electroconvulsive therapy: directions for future research. Psychopharmacol Bull 1994; 30:281-308
6. Mandel MR, Welch CA, Mieske M, McCormick M: Prediction of response to ECT in tricyclic-intolerant or tricyclic-resistant depressed patients. McLean Hosp J 1977; 4:203-209
7. Avery D, Lubrano A: Depression treated with imipramine and ECT: the DeCarolis study reconsidered. Am J Psychiatry 1979; 136:549-562
8. Paul SM, Extern I, Calil HM, Potter WZ, Chodoff P, Goodwin FK: Use of ECT with treatment-resistant depressed patients at the National Institute of Mental Health. Am J Psychiatry 1981; 138:486-489
9. Magni G, Fisman M, Helmes E: Clinical correlates of ECT-resistant depression in the elderly. J Clin Psychiatry 1988; 49:405-407
10. Dinan TG, Barry S: A comparison of electroconvulsive therapy with a combined lithium and tricyclic combination among depressed tricyclic nonresponders. Acta Psychiatr Scand 1989; 80: 97-100
11. Sackeim HA, Prudic J, Devanand DP: Treatment of medication-resistant depression with electroconvulsive therapy, in American Psychiatric Press Review of Psychiatry, vol 9. Edited by Tasman A, Goldfinger SM, Kaufmann CA. Washington, DC, American Psychiatric Press, 1990, pp 91-115
12. Medical Research Council: Clinical trial of the treatment of depressive illness. BMJ 1965; 3:881-886
13. Hamilton M: Drug resistant depressions: response to ECT. Pharmakopsychiatrie-Neuro-Psychopharmakologie 1974; 7:205-206
14. Kindler S, Shapira B, Hadjez J, Abramowitz M, Brom D, Lerer B: Factors influencing response to bilateral electroconvulsive therapy in major depression. Convulsive Therapy 1991; 7:245-254
15. Prudic J, Sackeim HA, Devanand DP: Medication resistance and clinical response to electroconvulsive therapy. Psychiatry Res 1990; 31:287-296
16. Sackeim HA, Decina P, Kanzler M, Kerr B, Malitz S: Effects of electrode placement on the efficacy of titrated, low-dose ECT. Am J Psychiatry 1987; 144:1449-1455
17. Sackeim HA, Prudic J, Devanand DP, Kiersky JE, Fitzsimons L, Moody BJ, McElhiney MC, Coleman EA, Settembrino JM: Effects of stimulus intensity and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy. N Engl J Med 1993; 328:839-846
18. Spitzer RL, Endicott J, Robins E: Research Diagnostic Criteria: rationale and reliability. Arch Gen Psychiatry 1978; 35:773-782
19. Endicott J, Spitzer RL: A diagnostic interview: the Schedule for Affective Disorders and Schizophrenia. Arch Gen Psychiatry 1978; 35:837-844
20. Hamilton M: Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 1967; 6:278-296
21. Spiker DG, Weiss JC, Dealy RS, Griffin SJ, Hanin I, Neil JF, Perel JM, Rossi AJ, Soloff PH: The pharmacological treatment of delusional depression. Am J Psychiatry 1985; 142:430-436
22. Rothschild AJ, Samson JA, Bessette MP, Carter-Campbell JT: Efficacy of combination fluoxetine and perphenazine in the treatment of psychotic depression. J Clin Psychiatry 1993; 54: 338-342
23. Buchan H, Johnstone E, McPherson K, Palmer RL, Crow TJ, Brandon S: Who benefits from electroconvulsive therapy? combined results of the Leicester and Northwick Park trials. Br J Psychiatry 1992; 160:355-359
24. Nobler MS, Sackeim HA: Prediction of response to electroconvulsive therapy: clinical and biological aspects, in Predictors of Response in Mood Disorders. Edited by Goodnick PJ. Washington, DC, American Psychiatric Press, 1996, pp 177-198
25. Sackeim HA, Prudic J, Devanand DP, Decina P, Kerr B, Malitz S: The impact of medication resistance and continuation pharmacotherapy on relapse following response to electroconvulsive therapy in major depression. J Clin Psychopharmacol 1990; 10: 96-104
26. Keller MB, Lavori PW, Klerman GL, Andreasen NC, Endicott J, Coryell W, Fawcett J, Rice JP, Hirschfeld RM: Low levels and lack of predictors of somatotherapy and psychotherapy received by depressed patients. Arch Gen Psychiatry 1986; 43:458-466
27. Shapira B, Gorfine M, Lerer B: A prospective study of lithium continuation therapy in depressed patients who have responded to electroconvulsive therapy. Convulsive Therapy 1995; 11:80-85
28. Hobson RF: Prognostic factors in ECT. J Neurol Neurosurg Psychiatry 1953; 16:275-281
29. Hamilton M, White J: Factors related to the outcome of depression treated with ECT. J Ment Sci 1960; 106:1031-1041
30. Kukopulos A, Reginaldi D, Tondo L, Bernabei A, Caliari B: Spontaneous length of depression and response to ECT. Psychol Med 1977; 7:625-629
31. Dunn CG, Quinlan D: Indicators of ECT response and non-response in the treatment of depression. J Clin Psychiatry 1978; 39:620-622
32. Andrade C, Gangadhar BN, Swaminath G, Channabasavanna SM: Predicting the outcome of endogenous depression following electroconvulsive therapy. Convulsive Therapy 1988; 4:169-174
33. Fraser RM, Glass IB: Unilateral and bilateral ECT in elderly patients: a comparative study. Acta Psychiatr Scand 1980; 62:13-31
34. Roberts JM: Prognostic factors in the electroshock treatment of depressive states, 1: clinical features from testing and examination. J Ment Sci 1959; 105:693-702
35. Roberts JM: Prognostic factors in the electroshock treatment of depressive states, 2: the application of specific tests. J Ment Sci 1959; 105:703-713
36. Pande AC, Krugler T, Haskett RF, Greden JF, Grunhaus LJ: Predictors of response to electroconvulsive therapy in major depressive disorder. Biol Psychiatry 1988; 24:91-93
37. Joyce PR, Paykel ES: Predictors of drug response in depression. Arch Gen Psychiatry 1989; 46:89-99
38. Nierenberg AA: The treatment of severe depression: is there an efficacy gap between SSRI and TCA antidepressant generations? J Clin Psychiatry 1994; 55(Sept suppl A):55-59
39. Danish University Antidepressant Group: Paroxetine: a selective serotonin reuptake inhibitor showing better tolerance, but weaker antidepressant effect than clomipramine in a controlled multicenter study. J Affect Disord 1990; 18:289-299
40. Roose SP, Classman AH, Attia E, Woodring S: Comparative efficacy of selective serotonin reuptake inhibitors and tricyclics in the treatment of melancholia. Am J Psychiatry 1994; 151:1735-1739